Sander Flaum, Flaum Navigators

Most recent articles by Sander Flaum, Flaum Navigators

Congress puts big price tag on innovation in pharma
Congress puts big price tag on innovation in pharma
Sander Flaum, Flaum Navigators
September 7, 2018
1:00 pm

It has become expensive to develop drugs — especially for specific mutations and small patient populations. But instead of helping pharma adapt, Congress is making innovation more costly.

Focus turns to future after Right to Try Act passes
Focus turns to future after Right to Try Act passes
Sander Flaum, Flaum Navigators
August 3, 2018
5:00 pm

Congress has finally passed the Right to Try Act, but does it go far enough?

Drugs’ value to patients eclipsed by price tags
Drugs’ value to patients eclipsed by price tags
Sander Flaum, Flaum Navigators
May 4, 2018
5:00 pm

Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.

Will PBMs take heat for high drug prices?
Will PBMs take heat for high drug prices?
Sander Flaum, Flaum Navigators
March 29, 2018
2:00 pm

PBMs began by providing a huge service to payers, but in recent years, they’ve begun to suck revenue from pharma manufacturers. Will they take some heat for high drug prices?

Can a nonprofit make generics great again?
Can a nonprofit make generics great again?
Sander Flaum, Flaum Navigators
March 7, 2018
12:00 pm

Acquisitions that were applauded a few years ago, such as Teva’s purchase of Allergan’s generic business, now look like lemons.

Did Congress just kill the Orphan Drug Act?
Did Congress just kill the Orphan Drug Act?
Sander Flaum, Flaum Navigators
February 13, 2018
12:00 pm

By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.

We Save Lives While Our Critics Complain
We Save Lives While Our Critics Complain
Sander Flaum, Flaum Navigators
January 25, 2018
12:00 pm

In his first press conference as president-elect, Donald Trump insisted pharma was “getting away with murder” due to expensive drug prices.

Gottlieb Eyes Prices, Not Lives
Gottlieb Eyes Prices, Not Lives
Sander Flaum, Flaum Navigators
December 14, 2017
12:00 pm

It turns out the real goal is going after Washington’s favorite whipping boy — high drug prices.

Who’s Getting Rich in Healthcare?
Who’s Getting Rich in Healthcare?
Sander Flaum, Flaum Navigators
October 30, 2017
11:00 am

Do you recall what President Trump tweeted right after Merck’s Kenneth Frazier resigned from his American Manufacturing Council?

AI Drug Design Could Save Lives
AI Drug Design Could Save Lives
Sander Flaum, Flaum Navigators
October 3, 2017
11:00 am

AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.

  • From Our Partners